GAMMA Investing’s INmune Bio INMB Stock Holding History

GAMMA Investing’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.62K	Hold	829	–	–	﹤0.01%	3994
2026 Q2	$1.35K	Sell	829 -775	-48%	-$1.07K	﹤0.01%	3812
2026 Q1	$1.81K	Buy	1,604 +1,423	+786%	+$2.03K	﹤0.01%	3691
2025 Q4	$282	Buy	+181	New	+$323	﹤0.01%	3974
2025 Q2	–	Sell	-44	Closed	-$344	–	3834
2025 Q1	$344	Buy	+44	New	+$349	﹤0.01%	3726

Other funds holding INMB

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Bill Few Associates Pittsburgh, Pennsylvania $485M AUM 17.8% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing's INMB Position: Q3 2026 in Review

GAMMA Investing held its INmune Bio (INMB) position steady in Q3 2026 at 829 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3994.

GAMMA Investing first reported a position in INMB in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.81K in Q1 2026. 6 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

GAMMA Investing held 829 shares of INmune Bio worth $1.62K as of Q3 2026.
GAMMA Investing left its INmune Bio share count unchanged in Q3 2026.
INmune Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3994 holding.
GAMMA Investing first reported a position in INmune Bio in Q1 2025 and has held it in 5 quarters since.
GAMMA Investing's INmune Bio position peaked at $1.81K in Q1 2026.
6 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.